-transparent.png){kind=logo}
Substituted pyrazoles as novel selective ligands for the human dopamine D4 receptor. 1998
S Bourrain, and
I Collins, and
J G Neduvelil, and
M Rowley, and
P D Leeson, and
S Patel, and
S Patel, and
F Emms, and
R Marwood, and
K L Chapman, and
A E Fletcher, and
G A Showell
Merck Sharp & Dohme Research Laboratories, Neuroscience Research Centre, Harlow, Essex, UK.
Two novel series of 3-(heterocyclylmethyl)pyrazoles have been synthesised and evaluated as ligands for the human dopamine D4 receptor. Compounds in series I (exemplified by 8k) have a phenyl ring joined to the 4-position of the pyrazole while those in series II (exemplified by 15j) have a 5-phenyl ring linked by a saturated chain to the 4-position of the pyrazole. Both series supplied compounds with excellent affinity for the human D4 and good selectivity over other dopamine receptors. Excellent selectivity over calcium, sodium, and potassium ion channels was also achieved.
Related Publications
S Bourrain, and
I Collins, and
J G Neduvelil, and
M Rowley, and
P D Leeson, and
S Patel, and
S Patel, and
F Emms, and
R Marwood, and
K L Chapman, and
A E Fletcher, and
G A Showell
July 1997,
Journal of medicinal chemistry,
S Bourrain, and
I Collins, and
J G Neduvelil, and
M Rowley, and
P D Leeson, and
S Patel, and
S Patel, and
F Emms, and
R Marwood, and
K L Chapman, and
A E Fletcher, and
G A Showell
August 1998,
Bioorganic & medicinal chemistry letters,
S Bourrain, and
I Collins, and
J G Neduvelil, and
M Rowley, and
P D Leeson, and
S Patel, and
S Patel, and
F Emms, and
R Marwood, and
K L Chapman, and
A E Fletcher, and
G A Showell
November 1999,
Bioorganic & medicinal chemistry letters,
S Bourrain, and
I Collins, and
J G Neduvelil, and
M Rowley, and
P D Leeson, and
S Patel, and
S Patel, and
F Emms, and
R Marwood, and
K L Chapman, and
A E Fletcher, and
G A Showell
April 2001,
Die Pharmazie,
S Bourrain, and
I Collins, and
J G Neduvelil, and
M Rowley, and
P D Leeson, and
S Patel, and
S Patel, and
F Emms, and
R Marwood, and
K L Chapman, and
A E Fletcher, and
G A Showell
January 1995,
Life sciences,
S Bourrain, and
I Collins, and
J G Neduvelil, and
M Rowley, and
P D Leeson, and
S Patel, and
S Patel, and
F Emms, and
R Marwood, and
K L Chapman, and
A E Fletcher, and
G A Showell
December 1997,
Journal of medicinal chemistry,
S Bourrain, and
I Collins, and
J G Neduvelil, and
M Rowley, and
P D Leeson, and
S Patel, and
S Patel, and
F Emms, and
R Marwood, and
K L Chapman, and
A E Fletcher, and
G A Showell
August 2016,
ChemMedChem,
S Bourrain, and
I Collins, and
J G Neduvelil, and
M Rowley, and
P D Leeson, and
S Patel, and
S Patel, and
F Emms, and
R Marwood, and
K L Chapman, and
A E Fletcher, and
G A Showell
June 1997,
Journal of medicinal chemistry,
S Bourrain, and
I Collins, and
J G Neduvelil, and
M Rowley, and
P D Leeson, and
S Patel, and
S Patel, and
F Emms, and
R Marwood, and
K L Chapman, and
A E Fletcher, and
G A Showell
November 1996,
Neuroreport,
S Bourrain, and
I Collins, and
J G Neduvelil, and
M Rowley, and
P D Leeson, and
S Patel, and
S Patel, and
F Emms, and
R Marwood, and
K L Chapman, and
A E Fletcher, and
G A Showell
December 2005,
Bioorganic & medicinal chemistry letters,
